Ariagen is a global life sciences investment firm that was established in 2012, with a portfolio of legendary companies and $2 billion of capital.
With offices in Silicon Valley, Shanghai, and New York, Ariagen is strategically positioned to make impactful investments in the field of life sciences.
Generated from the website